Literature DB >> 2760206

Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.

D D Dean1, J Martel-Pelletier, J P Pelletier, D S Howell, J F Woessner.   

Abstract

Cartilage specimens from tibial plateaus, obtained from 13 osteoarthritic (OA) patients and seven controls, were selected from three regions: zone A, center of fibrillated area; zone B, area adjacent to fibrillation, and zone C, remote region of plateau. Acid and neutral metalloproteinases and tissue inhibitor of metalloproteinase (TIMP) were extracted with 2 M guanidine. Methods were developed to selectively destroy either proteinases or TIMP to prevent cross-reaction during assay. Acid and neutral proteinases were elevated approximately 150% in OA; TIMP was elevated approximately 50%. A positive correlation (r = 0.50) was found between acid and neutral proteinase activities in OA, but not in controls. Both proteinases were elevated two-to threefold in zones A, B, and C. However, the self-active form of the acid metalloproteinase was elevated only in zones A and B (200%); it correlated well with the Mankin scores, whereas the total activities did not. TIMP was elevated (50%) only in zones A and B. Both the proteinase levels and the Mankin score were elevated to a greater extent in the medial, than in the lateral, compartment. Titration of TIMP against the two metalloproteinases indicates that there is a small excess of inhibitor over enzymes in normal cartilage. In OA, TIMP does not increase to the same extent as the proteinases; the resultant excess of proteinases over TIMP may contribute to cartilage breakdown.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760206      PMCID: PMC548932          DOI: 10.1172/JCI114215

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.

Authors:  Y Okada; H Nagase; E D Harris
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

2.  Pathogenesis of osteoarthritis.

Authors:  D S Howell
Journal:  Am J Med       Date:  1986-04-28       Impact factor: 4.965

3.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

4.  The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor.

Authors:  T E Cawston; G Murphy; E Mercer; W A Galloway; B L Hazleman; J J Reynolds
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

5.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.

Authors:  G S Herron; M J Banda; E J Clark; J Gavrilovic; Z Werb
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

6.  The extraction of a tissue collagenase associated with ovulation in the rat.

Authors:  T E Curry; D D Dean; J F Woessner; W J LeMaire
Journal:  Biol Reprod       Date:  1985-11       Impact factor: 4.285

7.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor.

Authors:  D F Carmichael; A Sommer; R C Thompson; D C Anderson; C G Smith; H G Welgus; G P Stricklin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.

Authors:  A J Docherty; A Lyons; B J Smith; E M Wright; P E Stephens; T J Harris; G Murphy; J J Reynolds
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

9.  Purification and characterization of an acid metalloproteinase from human articular cartilage.

Authors:  W Azzo; J F Woessner
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

10.  High levels of serum collagenase in premature labor--a potential biochemical marker.

Authors:  M Rajabi; D D Dean; J F Woessner
Journal:  Obstet Gynecol       Date:  1987-02       Impact factor: 7.661

View more
  102 in total

Review 1.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Effect of 1alpha,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo.

Authors:  D D Dean; B D Boyan; Z Schwart; O E Muniz; M R Carreno; S Maeda; D S Howell
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

3.  Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans.

Authors:  D D Dean; Z Schwartz; O E Muniz; R Gomez; L D Swain; D S Howell; B D Boyan
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

4.  Enzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains.

Authors:  Susanna Monaco; Valentina Sparano; Magda Gioia; Diego Sbardella; Donato Di Pierro; Stefano Marini; Massimo Coletta
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

5.  Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease.

Authors:  D G Sweet; K J McMahon; A E Curley; C M O'Connor; H L Halliday
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

6.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

7.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway.

Authors:  Richard F Loeser; Christopher B Forsyth; Allen M Samarel; Hee-Jeong Im
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

9.  Hydrostatic pressure induces expression of interleukin 6 and tumour necrosis factor alpha mRNAs in a chondrocyte-like cell line.

Authors:  K Takahashi; T Kubo; Y Arai; I Kitajima; M Takigawa; J Imanishi; Y Hirasawa
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

10.  The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells.

Authors:  M Shingu; Y Nagai; T Isayama; T Naono; M Nobunaga; Y Nagai
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.